CARL Key Statistics, Chart & Performance
The current stock price of CARL is 13.33 USD. In the past month the price decreased by -4.2%.
CARL Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to CARL.
CARL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CARL. CARL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
CARL Financial Highlights
Over the last trailing twelve months CARL reported a non-GAAP Earnings per Share(EPS) of -1.83. The EPS decreased by -31.49% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -34.45% | ||
| ROE | -43.55% | ||
| Debt/Equity | 0.14 |
CARL Forecast & Estimates
11 analysts have analysed CARL and the average price target is 20.2 USD. This implies a price increase of 51.51% is expected in the next year compared to the current price of 13.33.
For the next year, analysts expect an EPS growth of -30.83% and a revenue growth -6.41% for CARL
CARL Ownership
About CARL
Company Profile
Carlsmed, Inc. engages in the development of AI based technology solutions to the medical industry. The company is headquartered in Carlsbad, California and currently employs 100 full-time employees. The company went IPO on 2025-07-23. Its aprevo technology platform offers solutions for the entire surgical workflow, including pre-operative AI-enabled, surgical planning; intra-operative advanced visualization to support precision placement of aprevo interbody implants, and post-operative data collection and insights intended to improve the digital surgical planning process. Its pre-operative planning software utilizes standard-of-care diagnostic imaging and AI-enabled algorithms to develop personalized digital surgical plans and to design aprevo interbody implants for each patient's pathology and vertebral bone topography. Additionally, the aprevo technology platform supports the collection of real-world, post-operative data to inform its digital surgical planning process. Its platform is commercially available in the United States and is indicated for use in lumbar interbody fusion procedures.
Company Info
CARLSMED INC
1800 Aston Ave., Suite 100
Carlsbad CALIFORNIA US
Employees: 100
Phone: 17607661923
CARLSMED INC / CARL FAQ
What does CARLSMED INC do?
Carlsmed, Inc. engages in the development of AI based technology solutions to the medical industry. The company is headquartered in Carlsbad, California and currently employs 100 full-time employees. The company went IPO on 2025-07-23. Its aprevo technology platform offers solutions for the entire surgical workflow, including pre-operative AI-enabled, surgical planning; intra-operative advanced visualization to support precision placement of aprevo interbody implants, and post-operative data collection and insights intended to improve the digital surgical planning process. Its pre-operative planning software utilizes standard-of-care diagnostic imaging and AI-enabled algorithms to develop personalized digital surgical plans and to design aprevo interbody implants for each patient's pathology and vertebral bone topography. Additionally, the aprevo technology platform supports the collection of real-world, post-operative data to inform its digital surgical planning process. Its platform is commercially available in the United States and is indicated for use in lumbar interbody fusion procedures.
Can you provide the latest stock price for CARLSMED INC?
The current stock price of CARL is 13.33 USD. The price increased by 0.76% in the last trading session.
Does CARL stock pay dividends?
CARL does not pay a dividend.
What is the ChartMill rating of CARLSMED INC stock?
CARL has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Is CARLSMED INC (CARL) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CARL.
What is CARLSMED INC worth?
CARLSMED INC (CARL) has a market capitalization of 354.44M USD. This makes CARL a Small Cap stock.
What is the outstanding short interest for CARLSMED INC?
The outstanding short interest for CARLSMED INC (CARL) is 4.8% of its float.